|
^ HTBX: Intraday Hourly Forecast Similar Waves GapOpen Research Timing Gains Losses Strategies Practice |
Mon. Dec. 11, 2017 | Trading Signals: HTBX Stock Price Prediction and Forecast (Mon. Dec. 28, 2015 - Mon. May. 2, 2022)(Heat Biologics, Inc.)
| HTBX latest price $24.5140 (-7.82%) ($23.1070 - $27.6500) on Mon. Dec. 11, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.29% (three month average) | RSI | 28 | Latest Price | $24.5140(-7.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HTBX declines -4.1% a day on average for past five trading days. | Weekly Trend | HTBX declines -6.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HTBX advance at 0% a week (0% probability) ARKK(8%) KWEB(8%) MCHI(8%) QQQ(8%) SKYY(8%) | Factors Impacting HTBX price | HTBX will decline at least -2.145% in a week (0% probabilities). VCSH(-9%) VIXM(-5%) CEMB(-5%) BNDX(-4%) XLU(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.145% (StdDev 4.29%) | Hourly BBV | 0 () | Intraday Trend | -6.6% | | | |
|
1 - 5 Day Possible Target | $4.61(-81.19%) | Resistance Level | $32.15 | 5 Day Moving Average | $27.37(-10.43%) | 10 Day Moving Average | $29.78(-17.68%) | 20 Day Moving Average | $32.15(-23.75%) | To recent high | -53.9% | To recent low | 0% | Market Cap | $2.697b | | | | Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC. | $. HTBX price fluctuates within 13.62% (three month std-dev: 4.29%) daily (68% of days). Sample size 8 Average positive next day return: 6.69%(38%) Average negative next day return: -10.93%(63%)
Sample size 8 Average positive next three day return: 20.77%(50%) Average negative next three day return: -14.55%(50%)
Sample size 8 Average positive next weekly return: 22.95%(50%) Average negative next weekly return: -18.08%(50%)
Analysis News Options Weekly Chart Daily Chart 2 Month Daily Chart > 20180111 i | Date | ema100 | ema20 | ema10 | ema5 | Slow Hourly Trend | Fast Hourly Trend | Close | Pattern | Trade | P | SMA5 BBV | WTF | lsma10 Trend | ema5 Trend | ema10 Trend | Volume millions | Quarterly Strength | 100 Daily Trend | Daily Trend Force | Daily StdDev | Hourly BBV | BBV | RSI | VIXCD |
---|
|
|